Literature DB >> 18446311

Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy's disease).

C Paradas1, F Solano, F Carrillo, C Fernández, J Bautista, E Pintado, M Lucas.   

Abstract

We examined families with a history of spinal and bulbar muscular atrophy (SBMA) and found that six out of eight female carriers had a skewed inactivation of the wild-type chromosome. Under these genetic conditions, disease manifestations should be expected and therefore we sought neurological and other symptoms of subclinical SBMA. We did not find either clinical symptoms or electrophysiological signs of mutated AR gene in female carriers, despite skewed methylation of the wild-type allele. These findings suggest that skewed methylation of AR genes are not necessarily associated to clinical manifestations in female carriers of the expanded SBMA allele.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446311     DOI: 10.1007/s00415-008-0766-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Familial skewed X inactivation and X-linked mutations: unbalanced X inactivation is a powerful means to ascertain X-linked genes that affect cell proliferation.

Authors:  B R Migeon; C Haisley-Royster
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

Authors:  W R Kennedy; M Alter; J H Sung
Journal:  Neurology       Date:  1968-07       Impact factor: 9.910

4.  Skewed X inactivation of the normal allele in fully mutated female carriers determines the levels of FMRP in blood and the fragile X phenotype.

Authors:  Raquel Martínez; Victoria Bonilla-Henao; Antonio Jiménez; Miguel Lucas; Carmen Vega; Inmaculada Ramos; Francisco Sobrino; Elizabeth Pintado
Journal:  Mol Diagn       Date:  2005

5.  Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy.

Authors:  G Sobue; M Doyu; T Kachi; T Yasuda; E Mukai; T Kumagai; T Mitsuma
Journal:  J Neurol Sci       Date:  1993-07       Impact factor: 3.181

6.  Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families.

Authors:  C Mariotti; B Castellotti; D Pareyson; D Testa; M Eoli; C Antozzi; V Silani; R Marconi; F Tezzon; G Siciliano; C Marchini; C Gellera; S D Donato
Journal:  Neuromuscul Disord       Date:  2000-08       Impact factor: 4.296

Review 7.  Cell death in polyglutamine diseases.

Authors:  B O Evert; U Wüllner; T Klockgether
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

8.  X-inactivation patterns in carriers of X-linked myotubular myopathy.

Authors:  M Kristiansen; G P Knudsen; S M Tanner; M McEntagart; H Jungbluth; F Muntoni; C Sewry; S Gallati; K H Ørstavik; C Wallgren-Pettersson
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

9.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

10.  X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.

Authors:  J Azofeifa; T Voit; C Hübner; M Cremer
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

View more
  1 in total

Review 1.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.